Prescription drug · NDA
Emend (Aprepitant) NDC 0006-3066
Aprepitant 125 mg/1 · Powder, For suspension · Oral · Merck Sharp & Dohme LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0006-3066-03 | 00006306603 | 1 POUCH in 1 CARTON (0006-3066-03) / 1 POWDER, FOR SUSPENSION in 1 POUCH (0006-3066-01)Marketed from Dec 17, 2015 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Emend
- Generic name (nonproprietary)
- aprepitant
- Active ingredients
- Aprepitant — 125 mg/1
- Dosage form
- Powder, For suspension
- Route
- Oral
- Labeler
- Merck Sharp & Dohme LLCNDC labeler code 0006
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 207865
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 3A4 Inducers (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)Neurokinin 1 Antagonists (Mechanism)
- Identifiers
- Product ID 0006-3066_428f7828-6d1c-438b-a17d-b4af0700c740SPL ID 428f7828-6d1c-438b-a17d-b4af0700c740SPL set ID 696f9e80-9cae-403b-de9e-078343ce4713RxCUI 403810, 403811, 404465, 404466, 644088, 644278, 754508, 754509, 1729308, 1729311UNII 1NF15YR6UY
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400006306603followed by a unit qualifier and the quantityPackage 00006-3066-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
EMEND ® for oral suspension, in combination with other antiemetic agents, is indicated in patients 6 months of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC). EMEND ® capsules, in combination with other antiemetic agents, is indicated in patients 12 years of age and older for the prevention of: acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including hig…
Excerpt only. Read the full label for complete information.
About NDC 0006-3066
- What is NDC 0006-3066?
- 0006-3066 is the product NDC for Emend (aprepitant), Aprepitant 125 mg/1 powder, for suspension, listed with the FDA by Merck Sharp & Dohme LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Emend (Aprepitant).
- What is the active ingredient?
- Aprepitant.
- Who is the labeler?
- Merck Sharp & Dohme LLC, NDC labeler code 0006. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Emend?
- 5 other product NDCs are listed under this name. See all Emend NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Emend products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Emendfosaprepitant dimeglumine | Fosaprepitant dimeglumine 150 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | Merck Sharp & Dohme LLC | 0006-3061 | 00006-3061-00 |
| Emendaprepitant | Aprepitant 40 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0464 | — |
| Emendaprepitant | Aprepitant 80 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0461 | 00006-0461-0200006-0461-12 |
| Emendaprepitant | — | Kit | Merck Sharp & Dohme LLC | 0006-3862 | 00006-3862-0300006-3862-13 |
| Emendaprepitant | Aprepitant 125 mg/1 | CapsuleOral | Merck Sharp & Dohme LLC | 0006-0462 | — |